Partnering Opportunities In Cardio/Metabolics: “Everybody’s Looking And Nobody’s Got”
This article was originally published in The Pink Sheet Daily
Executive Summary
Representatives from J&J, GSK, Pfizer and Boehringer Ingelheim discuss their companies’ thinking in terms of cardiovascular/metabolic drug development and business development activity at the TAP conference.